Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 07 04; 381(1):92-94.
View in:
PubMed
subject areas
Drug Therapy, Combination
Drug Therapy, Combination
Female
Female
Glucocorticoids
Glucocorticoids
Humans
Humans
Immunologic Factors
Immunologic Factors
Jehovah's Witnesses
Jehovah's Witnesses
Middle Aged
Middle Aged
Plasma Exchange
Plasma Exchange
Purpura, Thrombotic Thrombocytopenic
Purpura, Thrombotic Thrombocytopenic
Rituximab
Rituximab
Single-Domain Antibodies
Single-Domain Antibodies
authors with profiles
James N George